{"url":"https://lda.senate.gov/api/v1/filings/6b22b265-d535-4b47-bc90-e27b0e6953dd/","filing_uuid":"6b22b265-d535-4b47-bc90-e27b0e6953dd","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2021,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/6b22b265-d535-4b47-bc90-e27b0e6953dd/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ryan Thompson","dt_posted":"2021-07-19T08:50:10.810000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1727 King Street","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401105683,"url":"https://lda.senate.gov/api/v1/registrants/401105683/","house_registrant_id":null,"name":"LIVE OAK STRATEGIES","description":"Government affairs and consulting","address_1":"9428 Mount Vernon Circle","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22309","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RYAN THOMPSON","contact_telephone":"+1 214-399-9639","dt_updated":"2026-07-06T14:55:05.097993-04:00"},"client":{"id":206267,"url":"https://lda.senate.gov/api/v1/clients/206267/","client_id":24,"name":"X. LABS","general_description":"Public safety and healthcare technologies","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-06-12"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Issues related to public safety and healthcare technologies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73605,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to public safety and healthcare technologies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73605,"prefix":null,"prefix_display":null,"first_name":"RYAN","nickname":null,"middle_name":null,"last_name":"THOMPSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}